[Form 4] PACS Group, Inc. Insider Trading Activity
PACS Group, Inc.'s Chief Legal Officer & Secretary, John Todd Mitchell, sold 80,152 shares of common stock in open-market transactions on May 15 and May 18, 2026. These sales, totaling over $3 million, were executed under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. Following these transactions, Mitchell still holds more than 800,000 PACS shares directly.
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against PACS Group, Inc. (NYSE:PACS) for alleged corporate wrongdoing. The firm is encouraging investors who purchased PACS securities before April 11, 2024, and continue to hold them, to join their investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis in securities class actions.
PACS Group chief legal officer sells $3.02 million in company stock
John Todd Mitchell, Chief Legal Officer of PACS Group, Inc., sold approximately $3.02 million worth of company stock through multiple transactions on May 15 and May 18, 2026. These sales were part of a Rule 10b5-1 trading plan. Despite a recent stock price decline, the company's shares had seen a 245% gain over the past year, and the company reported strong Q1 2026 financial results, exceeding EPS expectations.
PACS Group Price Target Raised to $52.00/Share From $50.00 by Truist Securities
Truist Securities has increased its price target for PACS Group (PACS) shares from $50.00 to $52.00. This adjustment indicates a positive outlook from the firm regarding the company's future stock performance.
How Pacs Group Inc. (PACS) Affects Rotational Strategy Timing
The article analyzes Pacs Group Inc. (NASDAQ: PACS) using AI models, indicating strong sentiment across all horizons and an overweight bias for the stock. It details various trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also provides multi-timeframe signal strengths and support/resistance levels for the stock.
Truist Raises Price Target on PACS Group to $52 From $50, Keeps Buy Rating
Truist has increased its price target for PACS Group (PACS) to $52 from $50, while maintaining a Buy rating on the stock. This adjustment reflects continued positive sentiment from analysts towards the healthcare facilities and services provider. The article also lists recent analyst actions from UBS and Oppenheimer, indicating growing confidence in PACS Group's financial performance and future prospects.
Big U.S. nursing-home group okays $250M buyback after 184% profit jump
PACS Group, a major U.S. post-acute healthcare company, reported a significant increase in its first-quarter 2026 net income, up 184.2% to $80.7 million, with revenue reaching $1.42 billion. Following this strong financial performance, the company's Board of Directors approved a $250 million share repurchase authorization. PACS also raised its full-year 2026 Adjusted EBITDA guidance to a range of $605 million to $625 million, demonstrating confidence in its continued growth and operational efficiency.
PACS Group (PACS) CFO awarded 48,426 RSUs vesting over three years
PACS Group's Chief Financial Officer, Carey P. Hendrickson, was granted 48,426 restricted stock units (RSUs) of Common Stock at no cash cost. These RSUs will vest in three equal annual installments starting May 14, 2026, provided he continues his service with the company. Following this transaction, Hendrickson directly holds 48,426 RSUs.
[144] PACS Group, Inc. SEC Filing
This article provides details of a Form 144 SEC filing by PACS Group, Inc. dated May 15, 2026. The filing indicates a proposed sale of 80,152 shares of common stock with an aggregate market value of $3,310,277.6, acquired through RSU Vesting on April 15, 2025. J.P. Morgan Securities LLC is listed as the broker for the sale on the NYSE.
PACS Group Q1 Earnings Call Highlights
PACS Group reported a strong Q1 2026, driven by higher occupancy, an improved skilled mix, and successful integration of acquired facilities. The company saw an 11% increase in revenue to $1.42 billion and significantly boosted net income and adjusted EBITDA. PACS also raised its full-year 2026 Adjusted EBITDA guidance and ended the quarter with substantial liquidity, while addressing ongoing government investigations and leadership changes.
PACS Group, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
PACS Group, Inc. reported strong Q1 results, exceeding revenue and statutory profit expectations. Despite this beat, analysts have maintained their previous revenue and EPS forecasts for 2026, suggesting no significant change in their outlook for the business. The consensus price target for PACS Group increased by 6.5% to US$48.83, reflecting confidence in the predictability of its earnings and an improving intrinsic value.
UBS Lifts PACS Group Price Target to $50 From $44, Maintains Buy Rating
UBS has increased its price target for PACS Group (PACS) to $50 from $44, while reiterating a "Buy" rating on the stock. This adjustment reflects continued analyst confidence in the healthcare company, which operates skilled nursing and assisted living facilities across 17 states. Another firm, Oppenheimer, also recently adjusted its price target for PACS Group to $48 from $42, maintaining an "Outperform" rating.
Results: PACS Group, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
The article reports that PACS Group, Inc. (NYSE:PACS) beat analyst expectations for its first-quarter earnings, with GAAP EPS coming in at US$0.40 against a forecast of US$0.32. Revenue also exceeded projections, reaching US$910.1 million compared to an estimated US$899.7 million. Following these positive results, analysts have updated their financial models and reiterated "buy" ratings, suggesting a potential 40% upside based on their consensus price target of US$27.83 per share.
PACS Group Q1 2026: Revenue Up 11%, EBITDA Surges 75%, But Is the Stock Now Overpriced?
PACS Group reported strong Q1 2026 results with an 11% revenue increase, a 75% surge in adjusted EBITDA, and diluted EPS of $0.50. Despite reaffirming revenue guidance and raising EBITDA guidance, the stock's 29% post-earnings jump has led TIKR's model to suggest it is currently overpriced, trading well above its historical P/E mean. The article evaluates the company's operating leverage, potential for future growth drivers, and risks, concluding that at its current price, the stock presents a challenging risk/reward profile.
Press Release: PACS Group, Inc. Reports First Quarter 2026 Results
The document is a press release from PACS Group, Inc. reporting its financial results for the first quarter of 2026. This indicates the company is publicly traded and regularly discloses its financial performance. The content of the press release itself is not provided, only the title.
Transcript : PACS Group, Inc., Q1 2026 Earnings Call, May 12, 2026
This article provides the transcript of the PACS Group, Inc. Q1 2026 Earnings Call held on May 12, 2026. The call features an operator's greeting and instructions for participants. Access to the full transcript is restricted to subscribers.
PACS Group Stock Jumps as Raised EBITDA Outlook Cuts Through Regulatory Noise
PACS Group (NYSE:PACS) shares surged approximately 23% following strong Q1 earnings, revenue, and an increased adjusted EBITDA outlook for 2026, alongside a new $250 million buyback authorization. Despite lingering SEC and DOJ probes and unresolved internal control issues, investors reacted positively to the company's financial performance, driven by improved facility occupancy and skilled nursing mix. The stock's jump reflects investor confidence in PACS's operational leverage and growth, even as regulatory challenges persist.
PACS Group earnings in focus: Can post-acute care leader sustain momentum?
PACS Group is scheduled to report its Q1 earnings, with analysts expecting a sequential decline in EPS but a year-over-year increase. Investors are focused on whether the post-acute care provider can maintain its growth streak amidst industry challenges like rising costs and reimbursement pressures, especially after acquiring 11 skilled nursing facilities. Despite potential near-term volatility and a stock pullback from its 52-week high, all six analysts still rate the stock a "buy" with significant upside potential.
PACS Group, Inc. (PACS) Q1 earnings and revenues surpass estimates
This article reports on PACS Group, Inc.'s strong Q1 performance, where the company exceeded both earnings and revenue estimates. While specific financial figures are not detailed in this snippet, the headline indicates a positive financial quarter for PACS.
PACS Group, Inc. Reports First Quarter 2026 Results
PACS Group, Inc. announced strong financial results for the first quarter of 2026, with revenue increasing by 11.2% to $1.42 billion and net income surging by 184.2% to $80.7 million. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $605 million to $625 million, demonstrating confidence in continued growth. Additionally, the Board of Directors approved a $250 million share repurchase authorization.
PACS Group earnings in focus: Can post-acute care leader sustain momentum?
PACS Group is set to report its first-quarter earnings, with analysts expecting a 4.76% year-over-year increase but a sequential decline from the previous quarter. Investors will be keenly watching to see if the decline is due to typical seasonality or margin pressures amidst industry headwinds like labor shortages and reimbursement challenges. The company's ability to integrate recent acquisitions and sustain profitability from its 324 facilities will be key, as analysts rate the stock a "buy" with significant upside potential despite current volatility.
New CFO and Alaska Expansion Might Change The Case For Investing In PACS Group (PACS)
PACS Group, Inc. has appointed Carey P. Hendrickson as its new CFO and expanded its reach with an acquisition in Anchorage, Alaska, including plans for a new skilled nursing facility. The article suggests that Hendrickson's experience could improve PACS Group's financial reporting and capital allocation, especially given its past issues. Investors are advised to monitor the integration of new facilities and the company's reliance on Medicaid and quality incentive programs.
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against PACS Group, Inc. (NYSE:PACS) for alleged corporate wrongdoing, encouraging investors who purchased securities before April 11, 2024, to join their investigation. The firm operates on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability. Affected shareholders can contact the firm for more information.
(PACS) and the Role of Price-Sensitive Allocations
This article provides an in-depth analysis of Pacs Group Inc. (NASDAQ: PACS) highlighting divergent market sentiment and an exceptional risk-reward setup. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis also includes multi-timeframe signal data with specific support and resistance levels.
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against PACS Group, Inc. (PACS) for corporate wrongdoing. The firm encourages investors who purchased PACS securities before April 11, 2024, and still hold them, to connect to assist in the investigation. The representation will be on a contingency fee basis, meaning investors only pay if the firm is successful.
PACS : Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026
PACS Group, Inc. (NYSE: PACS) announced its plan to release first-quarter 2026 financial results on Monday, May 11, 2026. Following the release, management will host an earnings call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss the results. Investors can access the webcast or dial into the call, with a replay available online for 30 days.
PACS Group Alaska Expansion: New 150-Bed Skilled Nursing Facility Planned by 2028
PACS Group, Inc. is expanding its presence in Alaska through the acquisition of Ridgeway Senior Living in Anchorage and plans to construct a new 150-bed skilled nursing facility by 2028. This expansion marks PACS' fourth facility in Alaska and aims to create a comprehensive care hub, supporting the state's post-acute care infrastructure. The project aligns with PACS' strategic growth to enhance care delivery and meet rising demand for long-term care services across its network of 325 communities in 17 states.
Press Release: PACS Group Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026
PACS Group announced its intention to release first-quarter 2026 earnings on Monday, May 11, 2026. The company will also host a conference call on Tuesday, May 12, 2026, to discuss these financial results with investors and the public. This announcement provides shareholders and analysts with key dates for accessing the company's latest financial performance.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into PACS Group, Inc. (NYSE: PACS) concerning potential corporate wrongdoing. The firm is encouraging stockholders who purchased PACS securities before April 11, 2024, and still hold them, to join the investigation. The goal is to recover investor capital and ensure corporate accountability.
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential corporate wrongdoing by PACS Group, Inc. (NYSE:PACS). The firm is encouraging stockholders who purchased PACS securities before April 11, 2024, and still hold them, to contact them to assist with the securities investigation. The investigation aims to restore investor capital and ensure corporate accountability.
PACS Group Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026
PACS Group, Inc. (NYSE: PACS) announced its intention to release first-quarter 2026 financial results on Monday, May 11, 2026. Management will host an earnings call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss these results, accessible via webcast on their investor relations website. The company, a major post-acute healthcare provider, encourages investors to monitor its public disclosures for material information.
PACS sets May 12 investor call after Q1 2026 results on May 11
PACS Group, Inc. (NYSE: PACS) announced its intention to release first-quarter 2026 financial results on Monday, May 11, 2026. Following the release, management will host an investor call on Tuesday, May 12, 2026, at 11:30 a.m. ET to discuss the results and related information. Investors can access the call via webcast or by dialing in, with a replay available for 30 days.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into PACS Group, Inc. (NYSE:PACS) regarding potential corporate wrongdoing involving the company and its officers/directors. Investors who purchased PACS securities before April 11, 2024, and still hold them, are encouraged to contact the firm to learn more about the investigation and assist in the process. The firm operates on a contingency fee basis, seeking reimbursement only if successful in recovering funds for investors.
PACS Group (PACS) Appoints Carey P. Hendrickson as Chief Financial Officer
PACS Group Inc. (NYSE: PACS) has appointed Carey P. Hendrickson as its new Chief Financial Officer, succeeding interim CFO Mark Hancock. Hendrickson brings nearly 40 years of financial leadership experience from companies like US Physical Therapy Inc. and Capital Senior Living Corporation. His expertise in healthcare finance and M&A integration is expected to support PACS Group's continued national expansion and growth.
PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
PACS Group, a post-acute healthcare platform, has acquired the operations of Ridgeway Senior Living in Anchorage, Alaska, marking its fourth location in the state. The company plans to construct a new 150-bed skilled nursing facility adjacent to the acquired property, with an estimated completion by 2028. This expansion increases PACS's portfolio to 325 communities across 17 states, reinforcing its mission to revolutionize post-acute care nationally.
PACS Group acquires Ridgeway Senior Living in Alaska
PACS Group, a $5.3 billion healthcare company, has acquired Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state. The company plans to construct a new 150-bed skilled nursing facility adjacent to the acquired property, aiming for completion by 2028. This expansion increases PACS' portfolio to 325 communities across 17 states, serving over 31,000 patients daily.
Press Release: PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
PACS Group has announced the acquisition of a skilled nursing facility in Alaska and plans for new construction. This strategic move aims to expand the company's presence and offer enhanced healthcare services in the region. The acquisition and planned development reflect PACS Group's commitment to growth and providing state-of-the-art skilled nursing communities.
PACS Group acquires Ridgeway Senior Living in Alaska By Investing.com
PACS Group, a $5.3 billion healthcare company, has acquired Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state. The company also plans to build a 150-bed skilled nursing facility adjacent to the acquired property. This expansion increases PACS' portfolio to 325 communities across 17 states, serving over 31,000 patients daily.
PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
PACS Group, Inc. announced the acquisition of Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state. The company also plans to construct a new 150-bed skilled nursing facility adjacent to the acquired property, with an estimated completion by 2028. This expansion aims to enhance post-acute care services and create a comprehensive continuum of care in Anchorage.
PACS Group (PACS) Appoints Carey P. Hendrickson as Chief Financial Officer
PACS Group Inc. (NYSE: PACS) has appointed Carey P. Hendrickson as its new Chief Financial Officer, succeeding co-founder Mark Hancock, who will retire from his executive role but remain on the board. Hendrickson brings nearly 40 years of financial experience, including previous CFO roles at US Physical Therapy Inc. and Capital Senior Living Corporation, which aligns with PACS Group's growth and national expansion strategies in the post-acute healthcare sector.
PACS turns to longtime healthcare finance chief for CFO role
PACS Group, a rapidly growing post-acute healthcare platform, has appointed Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Hendrickson brings almost four decades of financial leadership experience, including CFO roles in healthcare, and will succeed co-founder Mark Hancock, who is retiring but will remain on the Board of Directors. His appointment is expected to bolster PACS's financial operations as it continues to expand its national footprint.
PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
PACS Group, Inc. (NYSE: PACS) has appointed Carey P. Hendrickson as its new Chief Financial Officer, effective April 27, 2026. Hendrickson brings nearly four decades of financial leadership experience in healthcare to the role, succeeding Mark Hancock, who will retire as executive officer but remain on the Board of Directors. This appointment aims to strengthen PACS's financial leadership as it continues to expand its national footprint in post-acute healthcare.
PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
PACS Group, Inc. has announced the appointment of Carey P. Hendrickson as its new Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings nearly four decades of financial leadership experience in healthcare, senior living, and media sectors. He succeeds Mark Hancock, who will retire as an executive officer but remain on PACS's Board of Directors as Vice Chairman.
PACS Group (PACS) CFO Carey Hendrickson submits initial Form 3 ownership
PACS Group, Inc. filed an initial Form 3 for Chief Financial Officer Carey P. Hendrickson, establishing his insider status. The filing, dated April 27, 2026, indicates no reported transactions, acquisitions, or dispositions of shares, serving as a baseline disclosure of his ownership. This Form 3 primarily serves to formally acknowledge his role as CFO and an insider, requiring future disclosures for any changes in his beneficial ownership.
PACS Group Appoints New Chief Financial Officer Hendrickson
PACS Group Inc. has appointed Carey Hendrickson as its new Chief Financial Officer, effective April 27, 2026, succeeding co-founder Mark Hancock, who retires as an executive officer but remains vice chairman of the board. Hendrickson brings extensive public healthcare finance experience, aligning with PACS's growth strategy in the post-acute care sector. The transition balances continuity of the company's founding vision with new financial leadership to support its expanding operations and market position.
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
PACS Group, Inc. announced the planned retirement of its co-founder and CFO, Mark Hancock, effective June 30, 2026. Mr. Hancock, who co-founded PACS in 2013, played a pivotal role in expanding the company from two facilities to 323 across 17 states, with 2025 revenues of $5.29 billion. He will continue to serve on PACS's Board of Directors as Vice Chairman, and Carey P. Hendrickson has been named his successor as CFO.
PACS Group names Carey Hendrickson as chief financial officer
PACS Group, Inc. has appointed Carey P. Hendrickson as its new Chief Financial Officer. Hendrickson brings nearly 40 years of financial leadership experience in healthcare and senior living, previously serving as CFO for U.S. Physical Therapy, Inc. and Capital Senior Living Corporation. He succeeds Mark Hancock, who served as interim CFO and will retire from his executive role while remaining on the Board of Directors.
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
PACS Group, Inc. announced that co-founder and CFO Mark Hancock will retire on June 30, 2026, but will remain on the Board of Directors as Vice Chairman. Hancock, who co-founded PACS in 2013, was instrumental in its growth from two facilities to 323, achieving $5.29 billion in revenue in 2025. He will be succeeded by Carey P. Hendrickson as the new Chief Financial Officer.
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
PACS Group, Inc. announced the planned retirement of co-founder and CFO Mark Hancock, effective June 30, 2026. Hancock, who co-founded PACS in 2013, played a pivotal role in expanding the company from two facilities to 323 across 17 states, and will continue to serve as Vice Chairman on the Board of Directors. Carey P. Hendrickson has been named as his successor, bringing nearly four decades of financial leadership experience in healthcare.
PACS Group (NYSE: PACS) taps Carey Hendrickson as CFO as co-founder retires
PACS Group, Inc. has appointed Carey P. Hendrickson as its new Chief Financial Officer, effective April 27, 2026. This appointment follows the planned retirement of co-founder and Executive Vice Chairman Mark Hancock, who will step down as an executive officer on June 30, 2026, but will remain Vice Chairman of the Board. Hendrickson brings extensive financial leadership experience from previous CFO roles at U.S. Physical Therapy, Capital Senior Living, and Belo Corp.
